Nov 13 (Reuters) - Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from ...

On Tuesday, Express Scripts released its annual list of formulary exclusions, which included several drugs to treat rare diseases like hemophilia, HIV and hepatitis C. Many of these products, ...

Express Scripts (CI) announced a new electronic heath formulary this week, potentially transforming the way digital health solutions will be paid for in the near future. Back in May, the pharmacy ...

During a yearslong examination of drug prices, there’s been no shortage of criticism for growing list prices, and in recent months, some companies have heard the talk and lowered their prices. Now, ...

The digital health market continues to grow exponentially with apps that promote fitness, wellness and the prevention of chronic conditions as well as telehealth solutions and remote monitoring tools.

The influential US pharmacy benefit company Express Scripts has announced the digital apps that have made it into its first ever formulary for digital therapeutics, with products from health ...

Another major pharmacy benefit manager is adding Humira biosimilars to its formulary beginning next year. Express Scripts, which is part of Cigna's Evernorth subsidiary, said Monday that it will add ...

Pharmacy benefit manager Express Scripts announced Dec. 12 the creation of a formulary to increase provider trust in and patient access to digital and mobile health apps and devices, including those ...

Pharmacy benefit manager Express Scripts is launching a digital health formulary next year: a list of digital health tools, including smartphone apps and software-enabled medical devices, to help ...

Pharmacy benefit manager Express Scripts offers Viekira Pak at a discount and excludes the drug’s higher-priced competitors from its formulary. Shortly on the heels of the announcement that AbbVie’s ...

(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen ...